Association of enteroaggregative Escherichia coli with irritable bowel syndrome

Clinical Microbiology and Infection

Volumn 13, Issue 4, 2007, Pages 404-407

  Sobieszczanska B M ^a   Osek, J ^b   Wasko Czopnik D ^a   Dworniczek, E ^a   Jermakow, K ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

Adhesion; EAEC; Enteroaggregative Escherichia coli; Irritable bowel syndrome; Pathogenicity; Pathotypes

Indexed keywords

ADULT; ANIMAL CELL; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CELL ADHESION; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROBACTERIACEAE; EPITHELIUM CELL; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 33847774639     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01669.x     Document Type: Article

References (21)

1. Olden KW. The challenge of diagnosing irritable bowel syndrome. Rev Gastroenterol Disord 2003; 3 (suppl 3): S3-S11.
2. Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut 2001; 49: 743-745.
3. Garcia-Rodrigez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study. BMJ 1999; 318: 565-566.
4. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004; 10: 1802-1805.
5. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-201.
6. Cravioto A, Tello A, Navarro A et.al. Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet 1991; 337: 262-264.
7. Schmidt H, Knop CH, Franke S, Aleksic S, Heesemann J, Karch H. Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol 1995; 33: 701-705.
8. Robin CS. Estimating the importance of infection in IBS. Am J Gastroenterol 2003; 98: 238-241.
9. Spiller RC, Jenkins D, Thornley JP et.al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811.
10. Gwee KA, Leong YL, Graham C et.al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 400-406.
11. Swidinski A, Klilkin M, Ortner M. Alteration of bacterial concentration in colonic biopsies from patients with irritable bowel syndrome (IBS). Gastroenterology 1999; 116: A1.
12. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet 2001; i: 304-313.
13. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett 2006; 254: 12-18.
14. Huang DB, Okhuysen PC, Jiang ZD, DuPont HL. Enteroaggregative Escherichia coli: An emerging enteric pathogen. Am J Gastroenterol 2004; 99: 383-389.
15. Mayer HB, Wanke CA. Enteroaggregative Escherichia coli as a possible cause of diarrhea in an HIV-infected patients. N Engl J Med 1995; 332: 273-274.
16. Vila J, Vargas M, Henderson IR, Gascon J, Nataro JP. Enteroaggregative Escherichia coli virulence factors in traveler's diarrhea strains. J Infect Dis 2000; 182: 1780-1783.
17. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 1774-1778.
18. Freestone PP, Haigh RD, Williams PH, Lyte M. Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 1999; 172: 53-60.
19. Jiang ZD, Greenberg D, Nataro JP, Steffen R, DuPont HL. Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol 2002; 40: 4185-4190.
20. Hedlund M, Duan RD, Nilsson A, Svensson M, Karpman D, Svanberg C. Fimbriae, transmembrane signaling, and cell activation. J Infect Dis 2001; 183: S47-S50.
21. Steiner TS, Lima AA, Nataro JP, Guerrant RL. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 1998; 177: 88-96.